Redefining Clinical Hyperprogression: the Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy

Trie Arni Djunadi, Youjin Oh, Jeeyeon Lee, Jisang Yu, Liam Il-Young Chung, Yeunho Lee, Leeseul Kim, Timothy Hong, Soowon Lee, Zunairah Shah, Joo Hee Park, Sung Mi Yoon, Young Kwang Chae
doi: https://doi.org/10.1101/2024.01.04.23300116

Data Availability

All data produced in the present work are contained in the manuscript

Back to top
Posted January 05, 2024.
Download PDF

Supplementary Material

Data/Code
Email
Redefining Clinical Hyperprogression: the Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy
Trie Arni Djunadi, Youjin Oh, Jeeyeon Lee, Jisang Yu, Liam Il-Young Chung, Yeunho Lee, Leeseul Kim, Timothy Hong, Soowon Lee, Zunairah Shah, Joo Hee Park, Sung Mi Yoon, Young Kwang Chae
medRxiv 2024.01.04.23300116; doi: https://doi.org/10.1101/2024.01.04.23300116
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area